Myelodysplastic Syndrome

• FDA label_change · 2020-07-23
  FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approves a supplemental application for JADENU (deferasirox) from Novartis, updating the product labeling.

• FDA label_change · 2007-12-21
  FDA Approved: EXJADE — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for EXJADE (deferasirox) by Novartis Pharmaceuticals Corporation, updating the product labeling.